Genetics of perinatal brain injury in the preterm infant

Frontiers in Bioscience

Volumn 11, Issue 2 P.1199-1590, 2006, Pages 1371-1387

  Baier, Ronald John ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Brain Injury; Cytokine; Genetics; Intraventricular Hemorrhage; Periventricular Leukomalacia; Prematurity; Review

Indexed keywords

EID: 32944479606     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1890     Document Type: Review

References (199)

1. Larroque, B., S. Marret, P.-Y. Ancel, C. Arnaud, L. Marpeau, K. Supernant, V. Pierrat, J.-C. Roze, J. Matis, G. Cambonie, A. Burguet, M. Andre, M. Kaminski & G. Breart: White matter damage and intraventricular hemorrhage in very preterm infants: The EPIPAGE study. Journal of Pediatrics, The, 143, 477-483 (2003)
2. Lemons, J. A., C. R. Bauer, W. Oh, S. B. Korones, L. A. Papile, B. J. Stoll, J. Verter, M. Temprosa, L. L. Wright, R. A. Ehrenkranz, A. A. Fanaroff, A. Stark, W. Carlo, J. E. Tyson, E. F. Donovan, S. Shankaran & D. K. Stevenson: Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics, 107, E1 (2001)
3. Perlman, J. M.: White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Human Development, 53, 99-120 (1998)
4. Kissack, C. M., R. Garr, S. P. Wardle & A. M. Weindling: Postnatal Changes in Cerebral Oxygen Extraction in the Preterm Infant Are Associated with Intraventricular Hemorrhage and Hemorrhagic Parenchymal Infarction but Not Periventricular Leukomalacia. Pediatr Res, 56, 111-116 (2004)
5. Hambleton, G. & J. S. Wigglesworth: Origin of intraventricular haemorrhage in the preterm infant. Arch Dis Child, 51, 651-9 (1976)
6. Goddard-Finegold, J., D. Armstrong & R. S. Zeller: Intraventricular hemorrhage, following volume expansion after hypovolemic hypotension in the newborn beagle. J Pediatr, 100, 796-9 (1982)
7. Pryds, O., G. Greisen, H. Lou & B. Friis-Hansen: Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. Journal of Pediatrics, 115, 638-645 (1989)
8. Lou, H. C., N. A. Lassen & B. Friis-Hansen: Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr, 94, 118-21 (1979)
9. Shalak, L. F., A. R. Laptook, H. S. Jafri, O. Ramilo & J. M. Perlman: Clinical Chorioamnionitis, Elevated Cytokines, and Brain Injury in Term Infants. Pediatrics, 110, 673-680 (2002)
10. Gilles, F. H., R. A. Price, S. V. Kevy & W. Berenberg: Fibrinolytic activity in the ganglionic eminence of the premature human brain. Biol Neonate, 18, 426-32 (1971)
11. Hathaway, W. & J. Corrigan: Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis. Normal coagulation data for fetuses and newborn infants. Thromb Haemost, 65, 323-5 (1991)
12. Volpe, J. J.: Neurobiology of periventricular leukomalacia in the premature infant. Pediatric Research, 50, 553-562 (2001)
13. Rezaie, P. & A. Dean: Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology, 22, 106-32 (2002)
14. Takashima, S. & K. Tanaka: Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol, 35, 11-16 (1978)
15. De Reuck, J. L.: Cerebral angioarchitecture and perinatal brain lesions in premature and full-term infants. Acta Neurol Scand, 70, 391-5 (1984)
16. Altman, D. I., W. J. Powers, J. M. Perlman, P. Herscovitch, S. L. Volpe & J. J. Volpe: Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. Ann Neurol, 24, 218-26 (1988)
17. Paneth, N., R. Rudelli, W. Monte, E. Rodriguez, J. Pinto, R. Kairam & E. Kazam: White matter necrosis in very low birth weight infants: neuropathologic and ultrasonographic findings in infants surviving six days or longer. J Pediatr, 116, 975-84 (1990)
18. Iida, K., S. Takashima & K. Ueda: Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr Neurol, 13, 296-304 (1995)
19. Madtes, D. K., A. L. Elston, L. A. Kaback & J. G. Clark: Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology, 24, 599-607 (2001)
20. Follett, P. L., W. Deng, W. Dai, D. M. Talos, L. J. Massillon, P. A. Rosenberg, J. J. Volpe & F. E. Jensen: Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate. J. Neurosci., 24, 4412-4420 (2004)
21. Sherwin, C. & R. Fern: Acute Lipopolysaccharide-Mediated Injury in Neonatal White Matter Glia: Role of TNF-alpha, IL-1beta, and Calcium. J Immunol, 175, 155-161 (2005)
22. Chao, C. C., S. X. Hu, L. Ehrlich & P. K. Peterson: Interleukin-1 and Tumor Necrosis Factor-alpha Synergistically Mediate Neurotoxicity: Involvement of Nitric Oxide and of N-Methyl-D-aspartate Receptors. Brain, Behavior, and Immunity, 9, 355-365 (1995)
23. Kinney, H. C.: Human myelination and perinatal white matter disorders. Journal of the Neurological Sciences, 228, 190-192 (2005)
24. Feldhaus, B., I. D. Dietzel, R. Heumann & R. Berger: Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. Journal of the Society for Gynecologic Investigation, 11, 89-96 (2004)
25. Baud, O., J. Li, Y. Zhang, R. L. Neve, J. J. Volpe & P. A. Rosenberg: Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci, 20, 1713-26 (2004)
26. Schneider, J. A., D. C. Rees, Y. T. Liu & J. B. Clegg: Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet, 62, 1258-60 (1998)
27. Vohr, B. R., W. C. Allan, M. Westerveld, K. C. Schneider, K. H. Katz, R. W. Makuch & L. R. Ment: School-Age Outcomes of Very Low Birth Weight Infants in the Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics, 111, e340-346 (2003)
28. Linder, N., O. Haskin, O. Levit, G. Klinger, T. Prince, N. Naor, P. Turner, B. Karmazyn & L. Sirota: Risk Factors for Intraventricular Hemorrhage in Very Low Birth Weight Premature Infants: A Retrospective Case-Control Study. Pediatrics, 111, e590-595 (2003)
29. Holcroft, C. J., K. J. Blakemore, M. Allen & E. M. Graham: Association of prematurity and neonatal infection with neurologic morbidity in very low birth weight infants. Obstet Gynecol, 101, 1249-53 (2003)
30. Graham, E. M., C. J. Holcroft, K. K. Rai, P. K. Donohue & M. C. Allen: Neonatal cerebral white matter injury in preterm infants is associated with culture positive infections and only rarely with metabolic acidosis. Am J Obstet Gynecol, 191, 1305-10 (2004)
31. Debillon, T., C. Gras-Leguen, S. Leroy, J. Caillon, J. C. Roze & P. Gressens: Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Developmental Brain Research, 145, 39-48 (2003)
32. Duncan, J. R., M. L. Cock, J. P. Scheerlinck, K. T. Westcott, C. McLean, R. Harding & S. M. Rees: White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res, 52, 941-9 (2002)
33. Mallard, C., A.-K. Welin, D. Peebles, H. Hagberg & I. Kjellmer: White Matter Injury Following Systemic Endotoxemia or Asphyxia in the Fetal Sheep. Neurochemical Research, 28, 215-223 (2003)
34. Bell, M. J. & J. M. Hallenbeck: Effects of intrauterine inflammation on developing rat brain. J Neurosci Res, 70, 570-9 (2002)
35. Cai, Z., Y. Pang, S. Lin & P. G. Rhodes: Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res, 975, 37-47 (2003)
36. Lyng, K., M. Braakhuis, J. F. Froen, B. Stray-Pedersen & O. D. Saugstad: Inflammation increases vulnerability to hypoxia in newborn piglets: Effect of reoxygenation with 21% and 100% O2. American Journal of Obstetrics and Gynecology, 192, 1172-1178 (2005)
37. Verma, U., N. Tejani, S. Klein, W. Jeanty, H. Dweck, W. Zoma & G. Comacho: Obstetrical antecedents of neonatal periventricular leucomalacia. American Journal of Obstetrics and Gynecology, 170, 264 (1994)
38. Verma, U., N. Tejani, S. Klein, M. R. Reale, D. Beneck, R. Figueroa & P. Visintainer: Obstetrical antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. American Journal of Obstetrics and Gynecology, 176, 275-281 (1997)
39. Alexander, J. M., L. C. Gilstrap, S. M. Cox, D. M. McIntire & M. J. Leveno: Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstetrics & Gynecology, 91, 725-729 (1998)
40. Wharton, K. N., H. Pinar, B. S. Stonestreet, R. Tucker, K. R. McLean, M. Wallach & B. R. Vohr: Severe umbilical cord inflammation - a predictor of periventricular leukomalacia in very low birth weight infants. Early Human Development, 77, 77-87 (2004)
41. Neufeld, M. D., C. Frigon, A. S. Graham & B. A. Mueller: Maternal infection and risk of cerebral palsy in term and preterm infants. J Perinatol, 25, 108-13 (2005)
42. Acarin, L., B. Gonzalez & B. Castellano: Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. European Journal of Neuroscience, 12, 3505-3520 (2000)
43. Schobitz, B., D. A. M. Voorhuis & E. R. De Kloet: Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neuroscience Letters, 136, 189-192 (1992)
44. Kremlev, S. G. & C. Palmer: Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. Journal of Neuroimmunology, 162, 71-80 (2005)
45. Lee, Y. B., A. Nagai & S. U. Kim: Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res, 69, 94-103 (2002)
46. Lehnardt, S., C. Lachance, S. Patrizi, S. Lefebvre, P. L. Follett, F. E. Jensen, P. A. Rosenberg, J. J. Volpe & T. Vartanian: The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNS. J. Neurosci., 22, 2478-2486 (2002)
47. Szaflarski, J., D. Burtrum & F. S. Silverstein: Cerebral Hypoxia-Ischemia Stimulates Cytokine Gene Expression in Perinatal Rats. Stroke, 26, 1093-1100 (1995)
48. Hagberg, H., E. Gilland, E. Bona, L. Hanson, M. Hahin-Zoric, M. Blennow, M. Holst, A. McRae & O. Soder: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res, 40, 603-609 (1996)
49. Liu, X. H., D. Kwon, G. P. Schielke, G. Y. Yang, F. S. Silverstein & J. D. Barks: Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab, 19, 1099-108 (1999)
50. Berti, R., A. J. Williams, J. R. Moffett, S. L. Hale, L. C. Velarde, P. J. Elliott, C. Yao, J. R. Dave & F. C. Tortella: Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab, 22, 1068-79 (2002)
51. Cai, Z., Z.-L. Pan, Y. Pang, O. B. Evans & P. G. Rhodes: Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatric Research, 47, 64-72 (2000)
52. Shohami, E., I. Ginis & J. M. Hallenbeck: Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev, 10, 119-30 (1999)
53. Barone, F. C., B. Arvin, R. F. White, A. Miller, C. L. Webb, R. N. Willette, P. G. Lysko & G. Z. Feuerstein: Tumor Necrosis Factor-alpha: A Mediator of Focal Ischemic Brain Injury. Stroke, 28, 1233-1244 (1997)
54. Lavine, S. D., F. M. Hofman & B. V. Zlokovic: Circulating Antibody Against Tumor Necrosis Factor-Alpha Protects Rat Brain from Reperfusion Injury, 18, 52-58 (1998)
55. Yang, G.-Y., C. Gong, Z. Qin, W. Ye, Y. Mao & A. L. Bertz: Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport June 22, 9, 2131-2134 (1998)
56. Cai, Z., S. Lin, Y. Pang & P. G. Rhodes: Brain Injury Induced by Intracerebral Injection of Interleukin-1beta and Tumor Necrosis Factor-alpha in the Neonatal Rat. Pediatr Res, 56, 377-384 (2004)
57. Holmin, S. & T. Mathiesen: Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg, 92, 108-20 (2000)
58. Bruce, A., W. Boling, M. Kindy, J. Peschon, P. Kraemer, M. Carpenter, F. Holtsberg & M. Mattson: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med., 2, 788-94 (1996)
59. Gary, D. S., A. J. Bruce-Keller, M. S. Kindy & M. P. Mattson: Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab, 18, 1283-7 (1998)
60. Nawashiro, H., K. Tasaki, C. Ruetzler & J. Hallenbeck: TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab, 17, 483-490 (1997)
61. Galasso, J. M., P. Wang, D. Martin & F. S. Silverstein: Inhibition of TNF-alpha can attenuate or exacerbate excitotoxic injury in neonatal rat brain. Neuroreport, 11, 231-5 (2000)
62. Yamasaki, Y., N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama & K. Kogure: Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats. Stroke, 26, 676-681 (1995)
63. Garcia, J., K. Liu & J. Relton: Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol, 147, 1477-1486 (1995)
64. Hara, H., R. M. Friedlander, V. Gagliardini, C. Ayata, K. Fink, Z. Huang, M. Shimizu-Sasamata, J. Yuan & M. A. Moskowitz: Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. PNAS, 94, 2007-2012 (1997)
65. Relton, J. K., D. Martin, R. C. Thompson & D. A. Russell: Peripheral Administration of Interleukin-1 Receptor Antagonist Inhibits Brain Damage after Focal Cerebral Ischemia in the Rat. Experimental Neurology, 138, 206-213 (1996)
66. Loddick, S. A. & N. J. Rothwell: Neuroprotective Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Focal Cerebral Ischaemia in the Rat, 16, 932-940 (1996)
67. Friedlander, R. M., V. Gagliardini, H. Hara, K. B. Fink, W. Li, G. MacDonald, M. C. Fishman, A. H. Greenberg, M. A. Moskowitz & J. Yuan: Expression of a Dominant Negative Mutant of Interleukin-1beta Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury. J. Exp. Med., 185, 933-940 (1997)
68. Yang, G.-Y., Y.-J. Zhao, B. L. Davidson & A. L. Betz: Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Research, 751, 181-188 (1997)
69. Schielke, G. P., G.-Y. Yang, B. D. Shivers & A. L. Betz: Reduced Ischemic Brain Injury in Interleukin-1beta Converting Enzyme-Deficient Mice, 18, 180-185 (1998)
70. Yang, G.-Y., G. P. Schielke, C. Gong, Y. Mao, H.-L. Ge, X.-H. Liu & A. L. Betz: Expression of Tumor Necrosis Factor-Alpha and Intercellular Adhesion Molecule-1 After Focal Cerebral Ischemia in Interleukin-1[beta] Converting Enzyme Deficient Mice, 19, 1109-1117 (1999)
71. Basu, A., J. Lazovic, J. K. Krady, D. T. Mauger, R. P. Rothstein, M. B. Smith & S. W. Levison: Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic//ischemic injury. J Cereb Blood Flow Metab, 25, 17-29 (2005)
72. Boutin, H., R. A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura & N. J. Rothwell: Role of IL-1alpha and IL-1beta in Ischemic Brain Damage. J. Neurosci., 21, 5528-5534 (2001)
73. Xu, H., J. D. Barks, G. P. Schielke & F. S. Silverstein: Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme. Brain Res Mol Brain Res, 90, 57-67 (2001)
74. Shibayama, M., H. Kuchiwaki, S. Inao, K. Yoshida & M. Ito: Intercellular adhesion molecule-1 expression on glia following brain injury: participation of interleukin-1 beta. J Neurotrauma, 13, 801-8 (1996)
75. Pousset, F., S. Cremona, R. Dantzer, K. Kelley & P. Parnet: Interleukin-4 and interlenkin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study. Glia, 26, 12-21 (1999)
76. Lee, S. C., D. W. Dickson & C. F. Brosnan: Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav Immun, 9, 345-54 (1995)
77. Braida, D., P. Sacerdote, A. E. Panerai, M. Bianchi, A. M. Aloisi, S. Iosue & M. Sala: Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behavioural Brain Research, 153, 423-429 (2004)
78. Tilg, H., E. Trehu, M. Atkins, C. Dinarello & J. Mier: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 83, 113-118 (1994)
79. Loddick, S. A., A. V. Turnbull & N. J. Rothwell: Cerebral Interleukin-6 Is Neuroprotective During Permanent Focal Cerebral Ischemia in the Rat, 18, 176-179 (1998)
80. Winter, C. D., A. K. Pringle, G. F. Clough & M. K. Church: Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain, 127, 315-320 (2004)
81. Matsuda, S., T.-C. Wen, F. Morita, H. Otsuka, K. Igase, H. Yoshimura & M. Sakanaka: Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neuroscience Letters, 204, 109-112 (1996)
82. Penkowa, M., M. Giralt, J. Carrasco, H. Hadberg & J. Hidalgo: Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia, 32, 271-85 (2000)
83. Vallieres, L., I. L. Campbell, F. H. Gage & P. E. Sawchenko: Reduced Hippocampal Neurogenesis in Adult Transgenic Mice with Chronic Astrocytic Production of Interleukin-6. J. Neurosci., 22, 486-492 (2002)
84. Grilli, M., I. Barbieri, H. Basudev, R. Brusa, C. Casati, G. Lozza & E. Ongini: Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci, 12, 2265-72 (2000)
85. Dietrich, W. D., R. Busto & J. R. Bethea: Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol, 158, 444-50 (1999)
86. Spera, P. A., J. A. Ellison, G. Z. Feuerstein & F. C. Barone: IL-10 reduces rat brain injury following focal stroke. Neuroscience Letters, 251, 189-192 (1998)
87. Froen, J. F., B. H. Munkeby, B. Stray-Pedersen & O. D. Saugstad: Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Research, 942, 87-94 (2002)
88. Che, X., W. Ye, L. Panga, D.-C. Wu & G.-Y. Yang: Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Research, 902, 171-177 (2001)
89. Minami, M. & M. Satoh: Chemokines and their receptors in the brain: Pathophysiological roles in ischemic brain injury. Life Sciences, 74, 321-327 (2003)
90. Galasso, J., Y. Liu, J. Szaflarski, J. Warren & F. Silverstein: Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain. Neuroscience, 101, 737-744 (2000)
91. Galasso, J., M. Miller, R. Cowell, J. Harrison, J. Warren & F. Silverstein: Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp Neurol, 165, 295-305 (2000)
92. Hausmann, E. H. S., N. E. J. Berman, Y.-Y. Wang, J. B. Meara, G. W. Wood & R. M. Klein: Selective chemokine mRNA expression following brain injury. Brain Research, 788, 49-59 (1998)
93. Chen, Y., J. M. Hallenbeck, C. Ruetzler, D. Bol, K. Thomas, N. E. J. Berman & S. N. Vogel: Overexpression of Monocyte Chemoattractant Protein 1 in the Brain Exacerbates Ischemic Brain Injury and Is Associated With Recruitment of Inflammatory Cells, 23, 748-755 (2003)
94. Hughes, P. M., P. R. Allegrini, M. Rudin, V. H. Perry, A. K. Mir & C. Wiessner: Monocyte Chemoattractant Protein-1 Deficiency Is Protective in a Murine Stroke Model, 22, 308-317 (2002)
95. Cowell, R. M., H. Xu, J. M. Galasso & F. S. Silverstein: Hypoxic-Ischemic Injury Induces Macrophage Inflammatory Protein-1alpha Expression in Immature Rat Brain. Stroke, 33, 795-801 (2002)
96. Parish, C. L., D. I. Finkelstein, W. Tripanichkul, A. R. Satoskar, J. Drago & M. K. Horne: The Role of Interleukin-1, Interleukin-6, and Glia in Inducing Growth of Neuronal Terminal Arbors in Mice. J. Neurosci., 22, 8034-8041 (2002)
97. Yoon, B. H., R. Romero, C. J. Kim, J. N. Koo, G. Choe, H. C. Syn & J. G. Chi: High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. American Journal of Obstetrics and Gynecology, 177, 406-411 (1997)
98. Deguchi, K., M. Mizuguchi & S. Takashima: Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol, 14, 13-6 (1996)
99. Kadhim, H., B. Tabarki, G. Verellen, C. De Prez, A. M. Rona & G. Sebire: Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology, 56, 1278-84 (2001)
100. Kadhim, H. M. D. P., B. M. Tabarki, C. M. De Prez, A. M. Rona & G. M. D. P. Sebire: Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology April 9, 58, 1125-1128 (2002)
101. Ellison, V. J., T. J. Mocatta, C. C. Winterbourn, B. A. Darlow, J. J. Volpe & T. E. Inder: The Relationship of CSF and Plasma Cytokine Levels to Cerebral White Matter Injury in the Premature Newborn. Pediatr Res, 57, 282-286 (2005)
102. Duggan, P. J., E. F. Maalouf, T. L. Watts, M. H. Sullivan, S. J. Counsell, J. Allsop, L. Al-Nakib, M. A. Rutherford, M. Battin, I. Roberts & A. D. Edwards: Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet, 358, 1699-700 (2001)
103. Yoon, B. H., J. K. Jun, R. Romero, K. H. Park, R. Gomez, J.-H. Choi & I. O. Kim: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor alpha), neonatal brain white matter lesions, and cerebral palsy. American Journal of Obstetrics and Gynecology, 177, 19-26 (1997)
104. Yoon, B. H., R. Romero, S. H. Yang, J. K. Jun, I.-O. Kim, J.-H. Choi & H. C. Syn: Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. American Journal of Obstetrics and Gynecology, 174, 1433-1440 (1996)
105. Minagawa, K., Y. Tsuji, H. Ueda, K. Koyama, K. Tanizawa, H. Okamura & T. Hashimoto-Tamaoki: Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine, 17, 164-70 (2002)
106. Goepfert, A. R., W. W. Andrews, W. Carlo, P. S. Ramsey, S. P. Cliver, R. L. Goldenberg & J. C. Hauth: Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol, 191, 1375-81 (2004)
107. Martinez, E., R. Figueroa, D. Garry, P. Visintainer, K. Patel, U. Verma, P. B. Sehgal & N. Tejani: Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. Journal of Maternal-Fetal Investigation 101-107 (1998)
108. Tauscher, M. K., D. Berg, M. Brockmann, S. Seidenspinner, C. P. Speer & P. Groneck: Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates. Biol Neonate, 83, 166-70 (2003)
109. Duggan, P. J., E. F. Maalouf, T. L. Watts, M. H. F. Sullivan, S. J. Counsell, J. Allsop, L. Al-Nakib, M. A. Rutherford, M. Battin, I. Roberts & A. D. Edwards: Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. The Lancet, 358, 1699-1700 (2001)
110. Heep, A., D. Behrendt, P. Nitsch, R. Fimmers, P. Bartmann & J. Dembinski: Increased serum levels of interleukin 6 are associated with severe intraventricular haemorrhage in extremely premature infants. Arch. Dis. Child. Fetal Neonatal Ed., 88, F501-504 (2003)
111. Huang, H.-C., C.-L. Wang, L.-T. Huang, H. Chuang, C.-A. Liu, T.-Y. Hsu, C.-Y. Ou & K. D. Yang: Association of cord blood cytokines with prematurity and cerebral palsy. Early Human Development, 77, 29-36 (2004)
112. Kaukola, T., E. Satyaraj, D. D. Patel, V. T. Tchernev, B. G. Grimwade, S. F. Kingsmore, P. Koskela, O. Tammela, L. Vainionpaa, H. Pihko, T. Aarimaa & M. Hallman: Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol, 55, 186-94 (2004)
113. Kroeger, K. M., K. S. Carville & L. J. Abraham: The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol, 34, 391-9 (1997)
114. Braun, N., U. Michel, B. P. Ernst, R. Metzner, A. Bitsch, F. Weber & P. Rieckmann: Gene polymorphism at position -308 of the tumor-necrosis-factor- alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett, 215, 75-8 (1996)
115. Wilson, A. G., F. S. di Giovine, A. I. Blakemore & G. W. Duff: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet, 1, 353 (1992)
116. Louis, E., D. Franchimont, A. Piron, Y. Gevaert, N. Schaaf-Lafontaine, S. Roland, P. Mahieu, M. Malaise, D. De Groote, R. Louis & J. Belaiche: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol, 113, 401-6 (1998)
117. Huizinga, T. W. J., R. G. J. Westendorp, E. L. E. M. Bollen, V. Keijsers, B. M. N. Brinkman, J. A. M. Langermans, F. C. Breedveld, C. L. Verweij, L. van de Gaer & L. Dams: TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. Journal of Neuroimmunology, 72, 149-153 (1997)
118. Hamann A., Mantzoros C., Vidalpuig A. & Flier J. S.: Genetic Variability in the TNF-alpha Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM). Biochemical and Biophysical Research Communications, 211, 833-839 (1995)
119. Zimmerman, P. A., R. H. Guderian & T. B. Nutman: A new TNFA promoter allele identified in South American Blacks. Immunogenetics, 44, 485-6 (1996)
120. Higuchi, T., N. Seki, S. Kamizono, A. Yamada, A. Kimura, H. Kato & K. Itoh: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens, 51, 605-12 (1998)
121. Quasney, M. W., B. D. E, R. M. Cantor, Q. Zhang, C. Stroupe, H. Shike, J. F. Basttian, T. Matsubara, M. Fujiwara, K. Akimoto, J. W. Newburger & J. C. Burns: Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-alpha Levels in Children with Kawasaki Disease. Pediatr Res, 49, 686-690 (2001)
122. de Jong, B. A., R. G. J. Westendorp, A. M. Bakker & T. W. J. Huizinga: Polymorphisms in or near tumor necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production. Genes and Immunity, 3, 25-29 (2002)
123. Bayley, J. P., T. H. Ottenhoff & C. L. Verweij: Is there a future for TNF promoter polymorphisms? Genes Immun, 5, 315-329 (2004)
124. Heesen, M., B. Bloemeke, B. Bachmann-Mennenga & D. Kunz: The CD14-260 C-> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G -> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytes. Eur Cytokine Netw, 13, 230-3 (2002)
125. Knight, J. C., B. J. Keating & D. P. Kwiatkowski: Allele-specific repression of lymphotoxin-[alpha] by activated B cell factor-1. Nat Genet, 36, 394-399 (2004)
126. 1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun, 4, 420-6 (2003)
127. Kazzi, S. N. J., Y. R. Johnson, B. A. Bara, D. Kennedy, M. W. Quasney & S. Shankaran: Do Alleles of Tumor Necrosis Factor Gene Influence the Developmental Outcome of Very Low Birth Weight Infants? PAS, 57, 2090 (2005)
128. Nelson, K. B., J. M. Dambrosia, D. M. Iovannisci, S. Cheng, J. K. Grether & E. Lammer: Genetic Polymorphisms and Cerebral Palsy in Very Preterm Infants. Pediatr Res, 57, 494-499 (2005)
129. Reynard, M. P., D. Turner & C. V. Navarrete: Allele frequencies of polymorphisms of the tumor necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 gene in a North European Caucasoid group from the UK. European Journal of Immunogenetics, 27, 241-249 (2000)
130. Hoffmann, S. C., E. M. Stanley, E. D. Cox, B. S. DiMercurio, D. E. Koziol, D. M. Harlan, A. D. Kirk & P. J. Blair: Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant, 2, 560-7 (2002)
131. Conway, D. J., M. J. Holland, R. L. Bailey, A. E. Campbell, O. S. Mahdi, R. Jennings, E. Mbena & D. C. Mabey: Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun, 65, 1003-6 (1997)
132. El-Omar, E. M., M. Carrington, W. H. Chow, K. E. McColl, J. H. Bream, H. A. Young, J. Herrera, J. Lissowska, C. C. Yuan, N. Rothman, G. Lanyon, M. Martin, J. F. Fraumeni, Jr. & C. S. Rabkin: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature, 412, 99 (2001)
133. Hamajima, N., K. Matsuo, T. Saito, K. Tajima, K. Okuma, K. Yamao & S. Tominaga: Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res, 92, 383-9 (2001)
134. Kimura, R., T. Nishioka, A. Soemantri & T. Ishida: Cis-acting effect of the IL1B C-31T polymorphism on IL-1beta mRNA expression. Genes Immun, 5, 572-5 (2004)
135. Read, R. C., C. Cannings, S. C. Naylor, J. M. Timms, R. Maheswaran, R. Borrow, E. B. Kaczmarski & G. W. Duff: Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease. Ann Intern Med, 138, 534-41 (2003)
136. Arend, W. P.: The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev, 13, 323-40 (2002)
137. Danis, V. A., M. Millington, V. J. Hyland & D. Grennan: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol, 99, 303-10 (1995)
138. Mandrup-Poulsen, T., F. Pociot, J. Molvig, L. Shapiro, P. Nilsson, T. Emdal, M. Roder, L. L. Kjems, C. A. Dinarello & J. Nerup: Monokine antagonism is reduced in patients with IDDM. Diabetes, 43, 1242-7 (1994)
139. Hurme, M. & S. Santtila: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol, 28, 2598-602 (1998)
140. Baier, R. J., J. Loggins & K. Yanamandra: Association of the Interleukin-1beta -511 C/T Polymorphism with Intraventricular Hemorrhage and Periventricular Leukomalacia in ventilated very low birth weight infants. Paediatr. Child Health, 10, 25B (2005)
141. Yanamandra, K., J. Loggins & R. J. Baier: Gene-Environment Interaction Between Ureaplasma urealyticum, Interleukin-1β Polymorphism and Outcome in Very Low Birth Weight Infants. PAS, 57, 2234 (2005)
142. Osiri, M., J. McNicholl, L. W. Moreland & S. L. Bridges, Jr.: A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans. Genes Immun, 1, 166-7 (1999)
143. Tschentscher, F., A. Kalt, V. Hoffmann, J. Epplen & C. Hardt: Identification and efficient genotyping of an (A)n/(T)m polymorphism within the 5′ untranslated region of the human IL6 gene. Eur J Immunogenet, 27, 1-3 (2000)
144. Terry, C. F., V. Loukaci & F. R. Green: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem, 275, 18138-44 (2000)
145. Fishman, D., G. Faulds, R. Jeffery, V. Mohamed-Ali, J. S. Yudkin, S. Humphries & P. Woo: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369-76 (1998)
146. Kilpinen, S., J. Hulkkonen, X. Y. Wang & M. Hurme: The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw, 12, 62-8 (2001)
147. Brull, D. J., H. E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G. D. Lowe & S. E. Humphries: Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol, 21, 1458-63 (2001)
148. Kelberman, D., M. Fife, M. V. Rockman, D. J. Brull, P. Woo & S. E. Humphries: Analysis of common IL-6 promoter SNP variants and the AnTn tract in humans and primates and effects on plasma IL-6 levels following coronary artery bypass graft surgery. Biochim Biophys Acta, 1688, 160-7 (2004)
149. Bennermo, M., C. Held, S. Stemme, C. G. Ericsson, A. Silveira, F. Green & P. Tornvall: Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem, 50, 2136-40 (2004)
150. Jahromi, M. M., B. A. Millward & A. G. Demaine: A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res, 20, 885-8 (2000)
151. Rauramaa, R., S. B. Vaisanen, L. A. Luong, A. Schmidt-Trucksass, I. M. Penttila, C. Bouchard, J. Toyry & S. E. Humphries: Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol, 20, 2657-62 (2000)
152. Koss, K., J. Satsangi, K. I. Welsh & D. P. Jewell: Is interleukin-6 important in inflammatory bowel disease? Genes Immun, 1, 207-12 (2000)
153. Harding, D. R., S. Dhamrait, A. Whitelaw, S. E. Humphries, N. Marlow & H. E. Montgomery: Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth? Pediatrics, 114, 941-947 (2004)
154. Greisenegger, S., G. Endler, D. Haering, M. Schillinger, W. Lang, W. Lalouschek & C. Mannhalter: The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thrombosis Research, 110, 181-186 (2003)
155. Schluter, B., C. Raufhake, M. Erren, H. Schotte, F. Kipp, S. Rust, H. Van Aken, G. Assmann & E. Berendes: Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med, 30, 32-7 (2002)
156. Bazrafshani, M. R., A. H. Hajeer, W. E. Oilier & M. H. Thornhill: IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun, 3, 302-5 (2002)
157. Turner, D. M., D. M. Williams, D. Sankaran, M. Lazarus, P. J. Sinnott & I. V. Hutchinson: An investigation of polymorphisms in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1-8 (1997)
158. Westendorp, R. G., J. A. Langermans, T. W. Huizinga, A. H. Elouali, C. L. Verweij, D. I. Boomsma, J. P. Vandenbroucke & J. P. Vandenbrouke: Genetic influence on cytokine production and fatal meningococcal disease. Lancet, 349, 170-3 (1997)
159. Schaaf, B. M., F. Boehmke, H. Esnaashari, U. Seitzer, H. Kothe, M. Maass, P. Zabel & K. Dalhoff: Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med, 168, 476-80 (2003)
160. Haukim, N., J. L. Bidwell, A. J. Smith, L. J. Keen, G. Gallagher, R. Kimberly, T. Huizinga, M. F. McDermott, J. Oksenberg, J. McNicholl, F. Pociot, C. Hardt & S. D'Alfonso: Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun, 3, 313-30 (2002)
161. Lech-Maranda, E., L. Baseggio, J. Bienvenu, C. Charlot, F. Berger, D. Rigal, K. Warzocha, B. Coiffier & G. Salles: Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood, 103, 3529-34 (2004)
162. Kube, D., C. Platzer, A. von Knethen, H. Straub, H. Bohlen, M. Hafner & H. Tesch: Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine, 7, 1-7 (1995)
163. Eskdale, J., D. Kube, H. Tesch & G. Gallagher: Mapping of the human IL10 gene and further characterization of the 5″ flanking sequence. Immunogenetics, 46, 120-128 (1997)
164. 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol, 6, 193-7 (1998)
165. Mormann, M., H. Rieth, T. D. Hua, C. Assohou, M. Roupelieva, S. L. Hu, P. G. Kremsner, A. J. Luty & D. Kube: Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun, 5, 246-55 (2004)
166. De Groot, C. J., M. W. Jansen, R. M. Bertina, J. J. Schonkeren, F. M. Helmerhorst & T. W. Huizinga: Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun, 5, 313-4 (2004)
167. de Jong, B. A., R. G. Westendorp, J. Eskdale, B. M. Uitdehaag & T. W. Huizinga: Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol, 63, 281-5 (2002)
168. Yanamandra, K., P. Boggs, J. Loggins & R. J. Baier: Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol, 39, 426-32 (2005)
169. Dordelmann, M., J. Kerk, F. Dressler, D. B. Bartels, M.-J. Moennig, C. E. L. Dammann, T. Dork & O. Dammann: Interleukin-10 High Producer Allele and Reduced Risk for Neonatal Disorders: A Pilot Study. PAS, 57, 2634 (2005)
170. Yanamandra, K., J. Loggins & R. J. Baier: Interleukin-4 -590 C/T Polymorphism and Outcome in Very Low Birth Weight Infants. PAS, 57, 2223 (2005)
171. Kim, H. M., H. Y. Shin, H. J. Jeong, H. J. An, N. S. Kim, H. J. Chae, H. R. Kim, H. J. Song, K. Y. Kim, S. H. Baek, K. H. Cho, B. S. Moon & Y. M. Lee: Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. J Mol Neurosci, 14, 191-6 (2000)
172. Song, Z., V. Casolaro, R. Chen, S. N. Georas, D. Monos & S. J. Ono: Polymorphic nucleotides within the human IL-4 promoter that mediates overexpression of the gene. The Journal of Immunology, 156, 424-429 (1996)
173. Shirahata, A., T. Nakamura, M. Shimono, M. Kaneko & S. Tanaka: Blood coagulation findings and the efficacy of factor XIII concentrate in premature infants with intracranial hemorrhages. Thromb Res, 57, 755-63 (1990)
174. Lim, B. C., R. A. Ariens, A. M. Carter, J. W. Weisel & P. J. Grant: Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet, 361, 1424-31 (2003)
175. Catto, A. J., H. P. Kohler, S. Bannan, M. Stickland, A. Carter & P. J. Grant: Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke, 29, 813-6 (1998)
176. Catto, A. J., H. P. Kohler, J. Coore, M. W. Mansfield, M. H. Stickland & P. J. Grant: Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood, 93, 906-8 (1999)
177. Kohler, H. P., M. H. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola & P. J. Grant: Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost, 79, 8-13 (1998)
178. Elbaz, A., O. Poirier, S. Canaple, F. Chedru, F. Cambien & P. Amarenco: The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood, 95, 586-91 (2000)
179. Rosendaal, F. R., T. Koster, J. P. Vandenbroucke & P. H. Reitsma: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504-8 (1995)
180. Bertina, R. M., B. P. Koeleman, T. Koster, F. R. Rosendaal, R. J. Dirven, H. de Ronde, P. A. van der Velden & P. H. Reitsma: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-7 (1994)
181. Kalafatis, M., R. M. Bertina, M. D. Rand & K. G. Mann: Characterization of the molecular defect in factor VR506Q. J Biol Chem, 270, 4053-7 (1995)
182. Poort, S., F. Rosendaal, P. Reitsma & R. Bertina: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703 (1996)
183. Cumming, A., S. Keeney, A. Salden, M. Bhavnani, K. Shwe & C. Hay: The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol, 98, 353-355 (1997)
184. Jacques, P. F., A. G. Bostom, R. R. Williams, R. C. Ellison, J. H. Eckfeldt, I. H. Rosenberg, J. Selhub & R. Rozen: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 93, 7-9 (1996)
185. Hillier, C., P. Collins, D. Bowen, S. Bowley & C. Wiles: Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM, 91, 677-680 (1998)
186. Gopel, W., E. Kattner, J. Seidenberg, T. Kohlmann, H. Segerer, J. Muller & G. f. i. n. s. group: The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g. Journal of Pediatrics, 140, 688-692 (2002)
187. Petaja, J., L. Hiltunen & V. Fellman: Increased risk of intraventricular hemorrhage in preterm infants with thrombophillia. Pediatric Research, 49, 643-646 (2001)
188. Aronis, S., H. Bouza, H. Pergantou, Z. Kapsimalis, H. Platokouki & M. Xanthou Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage. Acta Paediatrica, 91, 87-91 (2002)
189. Gopel, W., L. Gortner, T. Kohlmann, C. Schultz & J. Muller: Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatrica, 90, 1021-1024 (2001)
190. Komlosi, K., V. Havasi, J. Bene, J. Storcz, J. Stankovics, G. Mohay, J. Weisenbach, G. Kosztolanyi & B. Melegh: Increased prevalence of factor V Leiden mutation in premature but not in full-term infants with grade I intracranial haemorrhage. Biol Neonate, 87, 56-9 (2005)
191. Melegh, B., J. Stankovics, A. Kis, A. Nagy, J. Storcz, H. Losonczy & K. Mehes: Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage. Eur J Pediatr 157, 261 (1998)
192. Stevenson, R. E., C. E. Schwartz, Y. Z. Du & M. J. Adams, Jr.: Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks. Am J Hum Genet, 60, 229-30 (1997)
193. Latif, S., J. Loggins, M. Nordberg & R. Baier: Association of the C677T mutation in the Methylenetetrahydrofolate reductase (MTHFR) gene and the development of chronic lung disease or death in ventilated extremely low birth weight infants. Pediatric Research, 53, 462A (2003)
194. Adams, K. M. & D. A. Eschenbach: The genetic contribution towards preterm delivery. Seminars in Fetal and Neonatal Medicine, 9, 445-452 (2004)
195. Hashimoto, K., H. Hasegawa, Y. Kida & Y. Takeuchi: Correlation between neuroimaging and neurological outcome in periventricular leukomalacia: Diagnostic criteria. Pediatrics International, 43, 240-245 (2001)
196. Szolnoki, Z., F. Somogyvari, A. Kondacs, M. Szabo, J. Bene, V. Havasi, K. Komlosi & B. Melegh: Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thrombosis Research, 109, 265-269 (2003)
197. Wheeler, R. D., H. Boutin, O. Touzani, G. N. Luheshi, K. Takeda & N. J. Rothwell: No Role for Interleukin-18 in Acute Murine Stroke-Induced Brain Injury, 23, 531-535 (2003)
198. Hedtjarn, M., A.-L. Leverin, K. Eriksson, K. Blomgren, C. Mallard & H. Hagberg: Interleukin-18 Involvement in Hypoxic-Ischemic Brain Injury. J. Neurosci., 22, 5910-5919 (2002)
199. Kadhim, H., B. Tabarki, C. Prez & G. Sebire: Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathologica, 105, 209-216 (2003)